Your browser doesn't support javascript.
loading
Evaluating new treatments for anaplastic thyroid cancer.
Coca-Pelaz, Andrés; Rodrigo, Juan P; Lopez, Fernando; Shah, Jatin P; Silver, Carl E; Al Ghuzlan, Abir; Menke-van der Houven van Oordt, C Willemien; Smallridge, Robert C; Shaha, Ashok R; Angelos, Peter; Mendenhall, William M; Piazza, Cesare; Olsen, Kerry D; Corry, June; Tufano, Ralph P; Sanabria, Alvaro; Nuyts, Sandra; Nathan, Cherie-Ann; Vander Poorten, Vincent; Dias, Fernando Luiz; Suarez, Carlos; Saba, Nabil F; de Graaf, Pim; Williams, Michelle D; Rinaldo, Alessandra; Ferlito, Alfio.
Afiliación
  • Coca-Pelaz A; Department of Otolaryngology, Hospital Universitario Central de Asturias, University of Oviedo, ISPA, IUOPA, CIBERONC, Oviedo, Spain.
  • Rodrigo JP; Department of Otolaryngology, Hospital Universitario Central de Asturias, University of Oviedo, ISPA, IUOPA, CIBERONC, Oviedo, Spain.
  • Lopez F; Department of Otolaryngology, Hospital Universitario Central de Asturias, University of Oviedo, ISPA, IUOPA, CIBERONC, Oviedo, Spain.
  • Shah JP; Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Silver CE; Departments of Surgery and Otolaryngology-Head and Neck Surgery, Albert Einstein College of Medicine, Bronx, NY, USA.
  • Al Ghuzlan A; Department of Medical Biology and Pathology, Institut Gustave Roussy, Villejuif, France.
  • Menke-van der Houven van Oordt CW; Department of Medical Oncology, Amsterdam Center for Endocrine and Neuro Endocrine Tumors (ACcENT), Amsterdam UMC location Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, Netherlands.
  • Smallridge RC; Division of Medicine, Mayo Clinic School of Medicine, Jacksonville, FL, USA.
  • Shaha AR; Head and Neck Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Angelos P; Department of Surgery and MacLean Center for Clinical Medical Ethics, The University of Chicago, Chicago, IL, USA.
  • Mendenhall WM; Department of Radiation Oncology, College of Medicine, University of Florida, Gainesville, FL, USA.
  • Piazza C; Otorhinolaryngology-Head and Neck Surgery Unit, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, ASST Spedali Civili, Brescia, Italy.
  • Olsen KD; Department of Otorhinolaryngology, Mayo Clinic, Rochester, MN, USA.
  • Corry J; Department Radiation Oncology, GenesisCare St Vincent's Hospital, Melbourne, Australia.
  • Tufano RP; FPG Thyroid and Parathyroid Center, Division of Head and Neck Endocrine Surgery, The Sarasota Memorial Health Care System, Sarasota, FL, USA.
  • Sanabria A; Department of Surgery, Universidad de Antioquia, CEXCA Centro de Excelencia en Enfermedades de Cabeza y cuello, Medellín, Colombia.
  • Nuyts S; Laboratory of Experimental Radiotherapy, Department of Oncology, University of Leuven, Belgium.
  • Nathan CA; Department of Radiation Oncology, Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
  • Vander Poorten V; Department of Otolaryngology-Head and Neck Surgery, Louisiana State University-Health Shreveport, Shreveport, LA, USA.
  • Dias FL; Department of Oncology, Section Head and Neck Oncology, KU Leuven, Leuven, Belgium.
  • Suarez C; Otorhinolaryngology, Head and Neck Surgery, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium.
  • Saba NF; Head and Neck Surgery Section, Instituto Nacional do Câncer (INCA), Pontifícia Universidade Católica do Rio de Janeiro, Rio de Janeiro, Brazil.
  • de Graaf P; Instituto de Investigación Sanitaria del Principado de Asturias, IUOPA, CIBERONC, Oviedo, Spain.
  • Williams MD; Department of Hematology and Medical Oncology, The Winship Cancer Institute of Emory University, Atlanta, GA, USA.
  • Rinaldo A; Cancer Center Amsterdam, Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Ferlito A; Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.
Expert Rev Anticancer Ther ; 22(11): 1239-1247, 2022 11.
Article en En | MEDLINE | ID: mdl-36283091
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Carcinoma Anaplásico de Tiroides Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Expert Rev Anticancer Ther Asunto de la revista: NEOPLASIAS / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: España
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Tiroides / Carcinoma Anaplásico de Tiroides Tipo de estudio: Guideline / Prognostic_studies Límite: Humans Idioma: En Revista: Expert Rev Anticancer Ther Asunto de la revista: NEOPLASIAS / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: España